Literature DB >> 19403900

Rationing antiretroviral therapy in Africa--treating too few, too late.

Nathan Ford1, Edward Mills, Alexandra Calmy.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19403900     DOI: 10.1056/NEJMp0902820

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.

Authors:  Ziad El-Khatib; Anna Mia Ekstrom; Johanna Ledwaba; Lerato Mohapi; Fatima Laher; Alan Karstaedt; Salome Charalambous; Max Petzold; David Katzenstein; Lynn Morris
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

Review 2.  Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.

Authors:  Eduard J Beck; Carlos Avila; Sofia Gerbase; Guy Harling; Paul De Lay
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

Review 3.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

4.  Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study.

Authors:  Catherine G Sutcliffe; Carolyn Bolton-Moore; Janneke H van Dijk; Matt Cotham; Bushimbwa Tambatamba; William J Moss
Journal:  BMC Pediatr       Date:  2010-07-30       Impact factor: 2.125

5.  Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.

Authors:  A K Njamnshi; A C Zoung-Kanyi Bissek; P Ongolo-Zogo; E N Tabah; A Z Lekoubou; F N Yepnjio; J Y Fonsah; C T Kuate; S A Angwafor; F Dema; D M Njamnshi; C Kouanfack; V de P Djientcheu; W F T Muna; G D Kanmogne
Journal:  J Neurol Sci       Date:  2009-07-24       Impact factor: 3.181

6.  Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006.

Authors:  Eduard J Beck; Sundhiya Mandalia; Gary Lo; Peter Sharott; Mike Youle; Jane Anderson; Guy Baily; Ray Brettle; Martin Fisher; Mark Gompels; George Kinghorn; Margaret Johnson; Brendan McCarron; Anton Pozniak; Alan Tang; John Walsh; David White; Ian Williams; Brian Gazzard
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

7.  Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element.

Authors:  Amy S Labar; Jennifer S Millman; Ellen Ruebush; Japheth A Opintan; Rima A Bishar; A Oladipo Aboderin; Mercy J Newman; Adebayo Lamikanra; Iruka N Okeke
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  Short-Term Rationing of Combination Antiretroviral Therapy: Impact on Morbidity, Mortality, and Loss to Follow-Up in a Large HIV Treatment Program in Western Kenya.

Authors:  April J Bell; Kara Wools-Kaloustian; Sylvester Kimaiyo; Hai Liu; Adrian Katschke; Changyu Shen; Gilbert Simiyu; Beverly S Musick; John E Sidle; Abraham Siika; Paula Braitstein
Journal:  AIDS Res Treat       Date:  2012-05-29

9.  Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.

Authors:  Ben Masiira; Kathy Baisley; Billy N Mayanja; Patrick Kazooba; Dermot Maher; Pontiano Kaleebu
Journal:  Glob Health Action       Date:  2014-01-15       Impact factor: 2.640

10.  Optimal starting point for antiretroviral HIV treatment in a town in Cameroon: a randomised controlled study.

Authors:  Knut Holtedahl; Daniel Salpou; Tonje Braaten; Zogoi Berved
Journal:  BMC Public Health       Date:  2014-08-10       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.